Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Hooper

Showing results (51-60 of 178) with videos related to

Pageof 18
Sort By:
Journal of Bacteriology|January 14, 2000
Expression of the multidrug resistance transporter NorA from Staphylococcus aureus is modified by a two-component regulatory systemB Fournier, R Aras, D C Hooper
Antimicrobial Agents and Chemotherapy|August 1, 1996
Quinolone resistance mutations in topoisomerase IV: relationship to the flqA locus and genetic evidence that topoisomerase IV is the primary target and DNA gyrase is the secondary target of fluoroquinolones in Staphylococcus aureusE Y Ng, M Trucksis, D C Hooper
Journal of Bacteriology|September 1, 1991
A novel locus conferring fluoroquinolone resistance in Staphylococcus aureusM Trucksis, J S Wolfson, D C Hooper
Medicine|August 26, 1998
Nocardia bacteremia. Report of 4 cases and review of the literatureD P Kontoyiannis, K Ruoff, D C Hooper
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 1, 1992
Synergism of trimethoprim and ciprofloxacin in vitro against clinical bacterial isolatesP Huovinen, J S Wolfson, D C Hooper
Antimicrobial Agents and Chemotherapy|June 1, 1994
Quinolone resistance mediated by norA: physiologic characterization and relationship to flqB, a quinolone resistance locus on the Staphylococcus aureus chromosomeE Y Ng, M Trucksis, D C Hooper
Annals of Internal Medicine|March 1, 1991
Emerging resistance to fluoroquinolones in staphylococci: an alertM Trucksis, D C Hooper, J S Wolfson
Annals of Neurology|February 24, 2001
Prospects for the treatment of multiple sclerosis by raising serum levels of uric acid, a scavenger of peroxynitriteH Koprowski, S V Spitsin, D C Hooper
Oncodevelopmental Biology and Medicine : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1982
Suppression of primary and secondary autologous mixed lymphocyte reactions by murine alphafetoproteinD C Hooper, E Pagida, R A Murgita
American Journal of Reproductive Immunology : AJRI : Official Journal of the American Society for the Immunology of Reproduction and the International Coordination Committee for Immunology of Reproduction|March 1, 1983
Naturally occurring non-T suppressor cells in pregnant and neonatal mice: some functional and phenotypic characteristicsD Hoskin, D C Hooper, R A Murgita
Pageof 18

Showing results (51-60 of 178) with videos related to

Sort By:
Pageof 18
Journal of Bacteriology|January 14, 2000
Expression of the multidrug resistance transporter NorA from Staphylococcus aureus is modified by a two-component regulatory systemB Fournier, R Aras, D C Hooper
Antimicrobial Agents and Chemotherapy|August 1, 1996
Quinolone resistance mutations in topoisomerase IV: relationship to the flqA locus and genetic evidence that topoisomerase IV is the primary target and DNA gyrase is the secondary target of fluoroquinolones in Staphylococcus aureusE Y Ng, M Trucksis, D C Hooper
Journal of Bacteriology|September 1, 1991
A novel locus conferring fluoroquinolone resistance in Staphylococcus aureusM Trucksis, J S Wolfson, D C Hooper
Medicine|August 26, 1998
Nocardia bacteremia. Report of 4 cases and review of the literatureD P Kontoyiannis, K Ruoff, D C Hooper
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 1, 1992
Synergism of trimethoprim and ciprofloxacin in vitro against clinical bacterial isolatesP Huovinen, J S Wolfson, D C Hooper
Antimicrobial Agents and Chemotherapy|June 1, 1994
Quinolone resistance mediated by norA: physiologic characterization and relationship to flqB, a quinolone resistance locus on the Staphylococcus aureus chromosomeE Y Ng, M Trucksis, D C Hooper
Annals of Internal Medicine|March 1, 1991
Emerging resistance to fluoroquinolones in staphylococci: an alertM Trucksis, D C Hooper, J S Wolfson
Annals of Neurology|February 24, 2001
Prospects for the treatment of multiple sclerosis by raising serum levels of uric acid, a scavenger of peroxynitriteH Koprowski, S V Spitsin, D C Hooper
Oncodevelopmental Biology and Medicine : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1982
Suppression of primary and secondary autologous mixed lymphocyte reactions by murine alphafetoproteinD C Hooper, E Pagida, R A Murgita
American Journal of Reproductive Immunology : AJRI : Official Journal of the American Society for the Immunology of Reproduction and the International Coordination Committee for Immunology of Reproduction|March 1, 1983
Naturally occurring non-T suppressor cells in pregnant and neonatal mice: some functional and phenotypic characteristicsD Hoskin, D C Hooper, R A Murgita
Pageof 18